APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biologic Therapeutics Drugs Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchBiologic Therapeutics Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Therapeutics Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologic Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Therapeutics Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Therapeutics Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Biologic Therapeutics Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologic Therapeutics Drugs include Aurobindo Pharma, Concord Biotech, H. Lundbeck, Retractable Technologies, Smith Medical, AstraZeneca, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biologic Therapeutics Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biologic Therapeutics Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologic Therapeutics Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologic Therapeutics Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biologic Therapeutics Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biologic Therapeutics Drugs Market by Company

Aurobindo Pharma

Concord Biotech

H. Lundbeck

Retractable Technologies

Smith Medical

AstraZeneca

GlaxoSmithKline

Pfizer

Merck

Novartis

Biologic Therapeutics Drugs Segment by Type

Yeast

Insects Cell Culture

Avian Cell Culture

Bacteria

Transgenics

Biologic Therapeutics Drugs Segment by Application

Diabetes

Anemia

Rheumatoid Arthritis

Cancer

Others

Biologic Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biologic Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Yeast Table 2. Major Company of Insects Cell Culture Table 3. Major Company of Avian Cell Culture Table 4. Major Company of Bacteria Table 5. Major Company of Transgenics Table 6. Global Biologic Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 8. Global Biologic Therapeutics Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Biologic Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Biologic Therapeutics Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Biologic Therapeutics Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Biologic Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 13. Global Biologic Therapeutics Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Biologic Therapeutics Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Biologic Therapeutics Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Biologic Therapeutics Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 18. North America Biologic Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 20. Europe Biologic Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Biologic Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 24. Latin America Biologic Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Biologic Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Biologic Therapeutics Drugs Industry Trends Table 28. Biologic Therapeutics Drugs Industry Drivers Table 29. Biologic Therapeutics Drugs Industry Opportunities and Challenges Table 30. Biologic Therapeutics Drugs Industry Restraints Table 31. Global Biologic Therapeutics Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Biologic Therapeutics Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Biologic Therapeutics Drugs Sales by Company (2021-2026) & (K Units) Table 34. Global Biologic Therapeutics Drugs Sales Share by Company (2021-2026) Table 35. Global Biologic Therapeutics Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Biologic Therapeutics Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Biologic Therapeutics Drugs Major Company Production Sites and Headquarters Table 38. Global Biologic Therapeutics Drugs Company, Product Type & Application Table 39. Global Biologic Therapeutics Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Biologic Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Biologic Therapeutics Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Biologic Therapeutics Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Biologic Therapeutics Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Biologic Therapeutics Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Biologic Therapeutics Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Biologic Therapeutics Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Biologic Therapeutics Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Biologic Therapeutics Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Biologic Therapeutics Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Biologic Therapeutics Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Biologic Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Biologic Therapeutics Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Biologic Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Biologic Therapeutics Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Biologic Therapeutics Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Biologic Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 60. Global Biologic Therapeutics Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Biologic Therapeutics Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Biologic Therapeutics Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Biologic Therapeutics Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 65. North America Biologic Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 67. Europe Biologic Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Biologic Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 71. Latin America Biologic Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Biologic Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Aurobindo Pharma Company Information Table 75. Aurobindo Pharma Business Overview Table 76. Aurobindo Pharma Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio Table 78. Aurobindo Pharma Recent Development Table 79. Concord Biotech Company Information Table 80. Concord Biotech Business Overview Table 81. Concord Biotech Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Concord Biotech Biologic Therapeutics Drugs Product Portfolio Table 83. Concord Biotech Recent Development Table 84. H. Lundbeck Company Information Table 85. H. Lundbeck Business Overview Table 86. H. Lundbeck Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. H. Lundbeck Biologic Therapeutics Drugs Product Portfolio Table 88. H. Lundbeck Recent Development Table 89. Retractable Technologies Company Information Table 90. Retractable Technologies Business Overview Table 91. Retractable Technologies Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Retractable Technologies Biologic Therapeutics Drugs Product Portfolio Table 93. Retractable Technologies Recent Development Table 94. Smith Medical Company Information Table 95. Smith Medical Business Overview Table 96. Smith Medical Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Smith Medical Biologic Therapeutics Drugs Product Portfolio Table 98. Smith Medical Recent Development Table 99. AstraZeneca Company Information Table 100. AstraZeneca Business Overview Table 101. AstraZeneca Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. AstraZeneca Biologic Therapeutics Drugs Product Portfolio Table 103. AstraZeneca Recent Development Table 104. GlaxoSmithKline Company Information Table 105. GlaxoSmithKline Business Overview Table 106. GlaxoSmithKline Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio Table 108. GlaxoSmithKline Recent Development Table 109. Pfizer Company Information Table 110. Pfizer Business Overview Table 111. Pfizer Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Pfizer Biologic Therapeutics Drugs Product Portfolio Table 113. Pfizer Recent Development Table 114. Merck Company Information Table 115. Merck Business Overview Table 116. Merck Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Merck Biologic Therapeutics Drugs Product Portfolio Table 118. Merck Recent Development Table 119. Novartis Company Information Table 120. Novartis Business Overview Table 121. Novartis Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Novartis Biologic Therapeutics Drugs Product Portfolio Table 123. Novartis Recent Development Table 124. North America Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. North America Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 126. North America Biologic Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 127. North America Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 128. North America Biologic Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 129. North America Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Biologic Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Biologic Therapeutics Drugs Market Share by Country (2021-2026) Table 132. North America Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Biologic Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 134. Europe Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Europe Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 136. Europe Biologic Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 137. Europe Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 138. Europe Biologic Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Biologic Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Biologic Therapeutics Drugs Market Share by Country (2021-2026) Table 142. Europe Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Biologic Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 146. Asia-Pacific Biologic Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 148. Asia-Pacific Biologic Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Biologic Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Biologic Therapeutics Drugs Market Share by Country (2021-2026) Table 152. Asia-Pacific Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Biologic Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 154. Latin America Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Latin America Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 156. Latin America Biologic Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 157. Latin America Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 158. Latin America Biologic Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Biologic Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Biologic Therapeutics Drugs Market Share by Country (2021-2026) Table 162. Latin America Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Biologic Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 166. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 168. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Biologic Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Biologic Therapeutics Drugs Market Share by Country (2021-2026) Table 172. Middle East and Africa Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Biologic Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Biologic Therapeutics Drugs Distributors List Table 177. Biologic Therapeutics Drugs Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Biologic Therapeutics Drugs Image Figure 2. Global Biologic Therapeutics Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Therapeutics Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Biologic Therapeutics Drugs Sales (2021-2032) & (K Units) Figure 5. Yeast Image Figure 6. Global Yeast Sales YoY Growth (2021-2032) & (K Units) Figure 7. Insects Cell Culture Image Figure 8. Global Insects Cell Culture Sales YoY Growth (2021-2032) & (K Units) Figure 9. Avian Cell Culture Image Figure 10. Global Avian Cell Culture Sales YoY Growth (2021-2032) & (K Units) Figure 11. Bacteria Image Figure 12. Global Bacteria Sales YoY Growth (2021-2032) & (K Units) Figure 13. Transgenics Image Figure 14. Global Transgenics Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Biologic Therapeutics Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Biologic Therapeutics Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Biologic Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Biologic Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Biologic Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Biologic Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Biologic Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Biologic Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Biologic Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Biologic Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Biologic Therapeutics Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Diabetes Image Figure 30. Global Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 31. Anemia Image Figure 32. Global Anemia Sales YoY Growth (2021-2032) & (K Units) Figure 33. Rheumatoid Arthritis Image Figure 34. Global Rheumatoid Arthritis Sales YoY Growth (2021-2032) & (K Units) Figure 35. Cancer Image Figure 36. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Biologic Therapeutics Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Biologic Therapeutics Drugs Market Share by Application 2025 VS 2032 Figure 41. North America Biologic Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 42. North America Biologic Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 43. Europe Biologic Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Europe Biologic Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Biologic Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Biologic Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 47. Latin America Biologic Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Biologic Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 51. North America Biologic Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Biologic Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Biologic Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Biologic Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Biologic Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Biologic Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Biologic Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Biologic Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Biologic Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Biologic Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Biologic Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Biologic Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Biologic Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Biologic Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Biologic Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Biologic Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Biologic Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Biologic Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Biologic Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Biologic Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Biologic Therapeutics Drugs Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Biologic Therapeutics Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast
  • Insects Cell Culture
  • Avian Cell Culture
  • Bacteria
  • Transgenics
Applications
  • Diabetes
  • Anemia
  • Rheumatoid Arthritis
  • Cancer
  • Others
Companies covered
  • Aurobindo Pharma
  • Concord Biotech
  • H. Lundbeck
  • Retractable Technologies
  • Smith Medical
  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biologic Therapeutics Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biologic Therapeutics Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biologic Therapeutics Drugs Market by Type
  6. 1.3.1 Yeast
  7. 1.3.2 Insects Cell Culture
  8. 1.3.3 Avian Cell Culture
  9. 1.3.4 Bacteria
  10. 1.3.5 Transgenics
  11. 1.4 Global Biologic Therapeutics Drugs Market Size by Type
  12. 1.4.1 Global Biologic Therapeutics Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Biologic Therapeutics Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Biologic Therapeutics Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Biologic Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Biologic Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Biologic Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Biologic Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Biologic Therapeutics Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biologic Therapeutics Drugs Industry Trends
  2. 2.2 Biologic Therapeutics Drugs Industry Drivers
  3. 2.3 Biologic Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Biologic Therapeutics Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biologic Therapeutics Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Biologic Therapeutics Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Biologic Therapeutics Drugs Price (2021-2026)
  4. 3.4 Global Biologic Therapeutics Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biologic Therapeutics Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Biologic Therapeutics Drugs Company, Product Type & Application
  7. 3.7 Global Biologic Therapeutics Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biologic Therapeutics Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biologic Therapeutics Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biologic Therapeutics Drugs Tier 1, Tier 2, and Tier 3
4 Biologic Therapeutics Drugs Regional Status and Outlook
  1. 4.1 Global Biologic Therapeutics Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biologic Therapeutics Drugs Historic Market Size by Region
  3. 4.2.1 Global Biologic Therapeutics Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biologic Therapeutics Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biologic Therapeutics Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biologic Therapeutics Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Biologic Therapeutics Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biologic Therapeutics Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biologic Therapeutics Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biologic Therapeutics Drugs by Application
  1. 5.1 Biologic Therapeutics Drugs Market by Application
  2. 5.1.1 Diabetes
  3. 5.1.2 Anemia
  4. 5.1.3 Rheumatoid Arthritis
  5. 5.1.4 Cancer
  6. 5.1.5 Others
  7. 5.2 Global Biologic Therapeutics Drugs Market Size by Application
  8. 5.2.1 Global Biologic Therapeutics Drugs Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Biologic Therapeutics Drugs Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Biologic Therapeutics Drugs Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Biologic Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Biologic Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Biologic Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Biologic Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Biologic Therapeutics Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aurobindo Pharma
  2. 6.1.1 Aurobindo Pharma Company Information
  3. 6.1.2 Aurobindo Pharma Business Overview
  4. 6.1.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio
  6. 6.1.5 Aurobindo Pharma Recent Developments
  7. 6.2 Concord Biotech
  8. 6.2.1 Concord Biotech Company Information
  9. 6.2.2 Concord Biotech Business Overview
  10. 6.2.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio
  12. 6.2.5 Concord Biotech Recent Developments
  13. 6.3 H. Lundbeck
  14. 6.3.1 H. Lundbeck Company Information
  15. 6.3.2 H. Lundbeck Business Overview
  16. 6.3.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio
  18. 6.3.5 H. Lundbeck Recent Developments
  19. 6.4 Retractable Technologies
  20. 6.4.1 Retractable Technologies Company Information
  21. 6.4.2 Retractable Technologies Business Overview
  22. 6.4.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio
  24. 6.4.5 Retractable Technologies Recent Developments
  25. 6.5 Smith Medical
  26. 6.5.1 Smith Medical Company Information
  27. 6.5.2 Smith Medical Business Overview
  28. 6.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio
  30. 6.5.5 Smith Medical Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Biologic Therapeutics Drugs Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Merck
  50. 6.9.1 Merck Company Information
  51. 6.9.2 Merck Business Overview
  52. 6.9.3 Merck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Biologic Therapeutics Drugs Product Portfolio
  54. 6.9.5 Merck Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Biologic Therapeutics Drugs Product Portfolio
  60. 6.10.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Biologic Therapeutics Drugs Sales by Country
  2. 7.1.1 North America Biologic Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biologic Therapeutics Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biologic Therapeutics Drugs Market Size by Country
  6. 7.2.1 North America Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biologic Therapeutics Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biologic Therapeutics Drugs Sales by Country
  2. 8.1.1 Europe Biologic Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biologic Therapeutics Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biologic Therapeutics Drugs Market Size by Country
  6. 8.2.1 Europe Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biologic Therapeutics Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biologic Therapeutics Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Biologic Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biologic Therapeutics Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biologic Therapeutics Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biologic Therapeutics Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biologic Therapeutics Drugs Sales by Country
  2. 10.1.1 South America Biologic Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biologic Therapeutics Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biologic Therapeutics Drugs Market Size by Country
  6. 10.2.1 South America Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biologic Therapeutics Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Biologic Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biologic Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biologic Therapeutics Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biologic Therapeutics Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biologic Therapeutics Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biologic Therapeutics Drugs Value Chain Analysis
  2. 12.1.1 Biologic Therapeutics Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biologic Therapeutics Drugs Production Mode & Process
  7. 12.2 Biologic Therapeutics Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biologic Therapeutics Drugs Distributors
  10. 12.2.3 Biologic Therapeutics Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst